FDA’s Regulation of Veterinary Regenerative Medicine 2012

Key Topics

• Biotherapeutic products intended for commercialization
• Veterinary cellular and tissue products
• FDA`s currently regulation of human cellular and tissue products products
• FDA`s regulation of veterinary regenerative medicine
• The potential for a drug / non-drug distinction
• The new animal drug approval process
• Strategies for mitigating FDA enforcement risks

Who should Attend

• Professors
• Regulatory Affairs Professionals
• Consultants
• Managers
• Research Analysts
• Scientists
• Insurers focusing on Representations & Warranties Insurance
• State Policy Officials
• Venture Capitalists
• Investment Analysts
• Financial analysts and investors watching the pharmaceutical, life sciences and biotech industries
• Stem Cell Companies, Biotech, Animal Drug Companies, Pharmaceutical Companies, Veterinarians, Veterinary Hospitals and Clinics